venBio Select Advisor LLC purchased $18.5M worth of shares in Immunomedics Inc. in June 2018

Jul 08, 2018
Insider Transactions
Background Information
Immunomedics, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. It operates through the United States, and Europe geographical segments. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.
venBio Select Advisors' investment objective is to achieve attractive returns with moderate risk. The firm invests primarily in the equity, debt and associated derivatives of companies operating in the life sciences sector and related industries.